Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1989 1
1991 1
1998 1
1999 1
2004 2
2010 1
2017 1
2021 1
2023 2
2024 2
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

13 results

Results by year

Filters applied: . Clear all
Page 1
IRAK4 inhibition dampens pathogenic processes driving inflammatory skin diseases.
Lavazais S, Jargosch M, Dupont S, Labéguère F, Menet C, Jagerschmidt C, Ohm F, Kupcsik L, Parent I, Cottereaux C, Marsais F, Oste L, Van de Water A, Christophe T, De Vos S, Fallon P, Lauffer F, Clément-Lacroix P, Eyerich K, Brys R. Lavazais S, et al. Among authors: parent i. Sci Transl Med. 2023 Feb 15;15(683):eabj3289. doi: 10.1126/scitranslmed.abj3289. Epub 2023 Feb 15. Sci Transl Med. 2023. PMID: 36791209
Design of a potent and selective dual JAK1/TYK2 inhibitor.
Mammoliti O, Menet C, Cottereaux C, Blanc J, De Blieck A, Coti G, Geney R, Oste L, Ostyn K, Palisse A, Quinton E, Schmitt B, Borgonovi M, Parent I, Jagerschmidt C, De Vos S, Vayssiere B, López-Ramos M, Shoji K, Brys R, Amantini D, Galien R, Joannesse C. Mammoliti O, et al. Among authors: parent i. Bioorg Med Chem. 2024 Nov 15;114:117932. doi: 10.1016/j.bmc.2024.117932. Epub 2024 Sep 30. Bioorg Med Chem. 2024. PMID: 39447537 Free article.
Prioritisation of infectious diseases from a public health perspective: a multi-criteria decision analysis study, France, 2024.
Ploin D, Alexandre M, Ventelou B, Che D, Coignard B, Boulanger N, Burucoa C, Caron F, Gallian P, Hansmann Y, Lienhardt C, Minodier P, Partouche H, Revest M, Saidani N, Salvat G, Vignier N, Floreani S; Collaborators’ group; Henry S, Pozzetto B, Hoen B; Experts of the criteria weighting group (alphabetically) Experts of the entity rating group (alphabetically) Experts from Santé publique France who provided the quantitative data (alphabetically). Ploin D, et al. Euro Surveill. 2024 Dec;29(50):2400074. doi: 10.2807/1560-7917.ES.2024.29.50.2400074. Euro Surveill. 2024. PMID: 39668764 Free PMC article.
Rubella control in France.
Lévy-Bruhl D, Six C, Parent I. Lévy-Bruhl D, et al. Among authors: parent i. Euro Surveill. 2004 Apr;9(4):15-6. Euro Surveill. 2004. PMID: 15192260
The epidemiology of invasive meningococcal disease in EU/EEA countries, 2004-2014.
Whittaker R, Dias JG, Ramliden M, Ködmön C, Economopoulou A, Beer N, Pastore Celentano L; ECDC network members for invasive meningococcal disease. Whittaker R, et al. Vaccine. 2017 Apr 11;35(16):2034-2041. doi: 10.1016/j.vaccine.2017.03.007. Epub 2017 Mar 14. Vaccine. 2017. PMID: 28314560 Free article.
Mpox outbreak in France: epidemiological characteristics and sexual behaviour of cases aged 15 years or older, 2022.
Krug C, Tarantola A, Chazelle E, Fougère E, Velter A, Guinard A, Souares Y, Mercier A, François C, Hamdad K, Tan-Lhernould L, Balestier A, Lahbib H, Etien N, Bernillon P, De Lauzun V, Durand J, Fayad M; Investigation Team; De Valk H, Beck F, Che D, Coignard B, Lot F, Mailles A; Investigation Team (alphabetically). Krug C, et al. Euro Surveill. 2023 Dec;28(50):2200923. doi: 10.2807/1560-7917.ES.2023.28.50.2200923. Euro Surveill. 2023. PMID: 38099346 Free PMC article.
13 results